Funded Early Detection and Screening Grants

Active/Completed

Topics

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Markowitz, Sanford D.	Case Western Reserve University United States	Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation	5U01CA271867-03	Matthew Young, Ph.D.
Mehta, Anand S.	Medical University Of South Carolina United States	Glycan Biomarkers for Cholangiocarcinoma	1R01CA289381-01A1	Sidney Fu, M.D.
Mello-Thoms, Claudia R	University Of Iowa United States	Satisfaction of Search in Breast Cancer Detection	5R01CA259048-05	Richard Mazurchuk, Ph.D.
Metzger, Gregory John	University Of Minnesota United States	Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI	5R01CA241159-04	Richard Mazurchuk, Ph.D.
Miyano, Masaru	Beckman Research Institute/City Of Hope United States	Evaluating the ELF5 Clock as a Biomarker in Breast Cancer Prevention Trials	1R03CA300614-01	Sidney Fu, M.D.
Mu, Ping	Yale University United States	Unveiling the Role of UBE2J1 as the E2 Ubiquitin Conjugating Enzyme in Androgen Receptor Degradation	7R01CA292949-02	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Nabavi, Sheida	University Of Connecticut Storrs United States	SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening	5R01CA297855-02	Claire Zhu, Ph.D.
Nappi, Lucia	Provincial Health Services Authority United States	Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration.	5R37CA264798-03	Guillermo Marquez, Ph.D.
Nath, Kavindra	University Of Pennsylvania United States	Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition	5R01CA228457-05
Neslund-Dudas, Christine Marie	Henry Ford Health + Michigan State University Health Sciences United States	HFH-MSU CSRN ACCrual Enrollment and Screening Site	3UG1CA287007-02S1	Elyse LeeVan, M.D., M.P.H.
Oberg, Ann Laura	Mayo Clinic Rochester United States	Management and Data Coordination Unit for PCDC	5U24CA274496-03	Guillermo Marquez, Ph.D.
Oskeritzian, Carole A	University Of South Carolina At Columbia United States	Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity	5R21CA274021-02	Guillermo Marquez, Ph.D.
Pandharipande, Pari Vijay	Ohio State University United States	Precision Management of Cystic Precursors to Pancreatic Cancer	5R01CA237133-06	Matthew Young, Ph.D.
Papadopoulos, Nickolas	Johns Hopkins University United States	Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids	5U01CA230691-07
Paulovich, Amanda G	Fred Hutchinson Cancer Center United States	Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment	5U2CCA271873-03	Sidney Fu, M.D.